Utama › Keadaan Pasca-COVID (Long COVID) › Maryland
Kajian klinikal Keadaan Pasca-COVID (Long COVID) di Maryland
21 kajian untuk Keadaan Pasca-COVID (Long COVID) sedang mencari peserta di lokasi di Maryland.
Bandar di Maryland
Teks kajian rasmi (Bahasa Inggeris)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Annapolis Internal Medicine - CCT Research ( Site 3700), Annapolis
- Kur Research - Columbia Medical ( Site 3767), Columbia
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06667700A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
- University of Maryland, School of Medicine, Center for Vaccine Development and Global Health, Baltimore
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 64 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07536308Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Annapolis
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Johns Hopkins Hospital, Baltimore
- Jadestone Clinical Research, Silver Spring
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07013474A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Centennial Medical Group, Columbia
- Jadestone Clinical Research, Silver Spring
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06679140Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 110 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06577467Viral Infections in Healthy and Immunocompromised Hosts
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
6 Months – 120 Years · Semua jantina · Dikemas kini 14 Sep 2026 · NCT01306084Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 100 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT04573062Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence
- Niaid/Lcim, Rockville
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
1 Day – 99 Years · Semua jantina · Dikemas kini 9 Sep 2026 · NCT04582903PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
- National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 70 · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06920628Respiratory Virus Sampling and Repository
- National Institutes of Health Clinical Center, Bethesda
- NIH Building 33 (NIAID), Bethesda
Mengambil pesertaKajian pemerhatian
Umur 3 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05266222Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome
- University of Maryland, Baltimore, Baltimore
Mengambil peserta
Umur 50 hingga 94 · Semua jantina · Dikemas kini 23 Jun 2026 · NCT05977179Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Mengambil pesertaSukarelawan sihat dialu-alukan
Sehingga umur 80 · Semua jantina · Dikemas kini 1 Jun 2026 · NCT05880108The Impact of COVID-19 on Maternal and Neonatal Outcomes
- Johns Hopkins Hospital, Baltimore
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 14 hingga 55 · Wanita · Dikemas kini 11 Mei 2026 · NCT05197621T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients
- The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore
Mengambil pesertaFasa 1
Umur 2 hingga 80 · Semua jantina · Dikemas kini 12 Mac 2026 · NCT05141058Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2
- Kennedy Krieger Institute, Baltimore
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 75 · Semua jantina · Dikemas kini 12 Dis 2025 · NCT07278388Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
- Johns Hopkins University, Baltimore
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Nov 2025 · NCT06128928Home-Based Exercise Tele-Rehabilitation After COVID-19
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 50 hingga 85 · Semua jantina · Dikemas kini 10 Nov 2025 · NCT05425264EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
- Johns Hopkins Hospital, Baltimore
Mengambil pesertaFasa 3
Umur 0 hingga 17 · Semua jantina · Dikemas kini 17 Jul 2025 · NCT05261139Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)
- All Natural Medicine Clinic, LLC, Rockville
Mengambil pesertaFasa 1/2
Semua umur · Semua jantina · Dikemas kini 19 Feb 2025 · NCT04790240Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.
- NIH Clinical Center, Bethesda
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
Umur 18 hingga 65 · Semua jantina · Dikemas kini 27 Nov 2024 · NCT06441955Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.